AIDS, HIV & STDs Research Reports
Herpes Zoster Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| Herpes Zoster - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| HIV / AIDS - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes Simplex - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-1 Infection - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Syphilis Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes Zoster - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Genital Herpes - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| The Global Market for AIDS/HIV Testing and Treatment
Topics: AIDS, HIV & STDs, Microbiology & Virology
| Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets
Topics: AIDS, HIV & STDs, Hepatitis
| HIV-Associated Lipodystrophy Syndrome - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-Related Lymphoma - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Aids Associated Dementia - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery, CNS/Neurology
| Aids-Related Kaposi's Sarcoma - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes zoster infections Therapy Pipeline Report
Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS HIV Therapy Pipeline Report
Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes Simplex Virus Infection Therapy Pipeline Report
Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS - Related Cancers Global Clinical Trials Review, Q4, 2010
Topics: AIDS, HIV & STDs, Drug Discovery, Oncology/Hematology
| HIV / AIDS Global Clinical Trials Review, Q4, 2010
Topics: AIDS, HIV & STDs, Drug Discovery, Clinical Trial
| Herpes Simplex - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs
| Aids - Related Cancers - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs, Oncology/Hematology
| Lipodystrophy - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs, Drug Discovery
| Human Papillomavirus - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs, Oncology/Hematology, Obstetrics/Gynecology
| AIDS Malignancy Clinical Trials Consortium - Developmental Therapeutics Review - Q4 2010
Topics: AIDS, HIV & STDs
| Herpes Zoster - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs
| HIV / AIDS - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs
| HIV-1 Infection - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs
| Genital Herpes - Pipeline Review, Q4 2010
Topics: AIDS, HIV & STDs
| French National Agency for Research on AIDS and Viral Hepatitis - Developmental Therapeutics Review - Q4 2010
Topics: AIDS, HIV & STDs, Facilities Company Reports
| AIDS Associated Malignancies Clinical Trials Consortium - Developmental Therapeutics Review - Q4 2010
Topics: AIDS, HIV & STDs
| AIDS Malignancy Clinical Trials Consortium - Product Pipeline Review - Q4 2010
Topics: AIDS, HIV & STDs, Pharmaceuticals Company Reports
| AIDS Associated Malignancies Clinical Trials Consortium - Product Pipeline Review - Q4 2010
Topics: AIDS, HIV & STDs, Pharmaceuticals Company Reports
| AIDS_HIV Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs
| Disease and Therapy Review: Oral Herpes
Topics: AIDS, HIV & STDs
| HIV/AIDS Testing
Topics: AIDS, HIV & STDs
Regions: Global
| STD Diagnostics--Trends and Opportunities (Technical Insights)
Topics: AIDS, HIV & STDs, Microbiology & Virology, Point-of-Care
| Stakeholder Opinions: Sexually Transmitted Diseases - An underestimated threat lacking interventions to prevent transmission
Topics: AIDS, HIV & STDs, General In Vitro Diagnostics, Vaccines
| Forecast Insight: HIV - Increasing dominance of fixed dose combinations raises bar for single agents
Topics: AIDS, HIV & STDs
| The 2011 Gonorrhea Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
Topics: AIDS, HIV & STDs, Drug Discovery
| The 2011 Herpes Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
Topics: AIDS, HIV & STDs, Microbiology & Virology
Regions: Japan, United States
| The 2011 Chlamydia Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
Topics: AIDS, HIV & STDs, Drug Discovery
| The 2011 HIV/AIDS Diagnostics Market: US, Europe, Japan--Sales Forecasts and Supplier Shares by Country
Topics: AIDS, HIV & STDs
Regions: Japan, United States, Europe
| The 2011 Syphilis Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
Topics: AIDS, HIV & STDs, General In Vitro Diagnostics
| Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
Topics: AIDS, HIV & STDs, Research & Development, Drug Discovery
Regions: India, Russia, Brazil
| The Antivirals Pipeline: Competitive Review
Topics: AIDS, HIV & STDs, Hepatitis, Research & Development, Drug Discovery
| Competitor Analysis: HPV Vaccines
Topics: AIDS, HIV & STDs, Vaccines, Women's Health, Cancer Vaccines
| Infectious Disease Treatments: Global Markets
Topics: AIDS, HIV & STDs, Hepatitis, Tuberculosis, Disease Management, Vaccines, Infectious Diseases
Regions: Global
| The 2011 Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies for Suppliers
Topics: AIDS, HIV & STDs, General In Vitro Diagnostics
| HIV Drugs
Topics: AIDS, HIV & STDs, Research & Development
Regions: Global
| The 2011 German Infectious Disease Testing Market
Topics: AIDS, HIV & STDs, General In Vitro Diagnostics
Regions: Germany
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
